Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/14563
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorROCHA, Luiza F.-
dc.contributor.authorASSAD, Ana Paula Luppino-
dc.contributor.authorMARANGONI, Roberta G.-
dc.contributor.authorRIO, Ana Paula Toledo Del-
dc.contributor.authorMARQUES-NETO, Joao Francisco-
dc.contributor.authorSAMPAIO-BARROS, Percival D.-
dc.date.accessioned2016-07-18T12:43:44Z-
dc.date.available2016-07-18T12:43:44Z-
dc.date.issued2016-
dc.identifier.citationRHEUMATOLOGY INTERNATIONAL, v.36, n.5, p.697-702, 2016-
dc.identifier.issn0172-8172-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/14563-
dc.description.abstractThe objective of this study is to describe the characteristics of patients with Erasmus syndrome (ES) in a large SSc Brazilian cohort. Nine hundred and forty-seven SSc patients attended at the Scleroderma Outpatient Clinic at two academic medical centers in Brazil and classified as SSc according to the ACR/EULAR criteria were retrospectively studied. Information on demographics, clinical, and laboratory features was obtained by chart review. ES patients had their HLA class II characterized by PCR-SSO method as available. Among the 947 SSc patients studied, nine (0.9 %) had ES. These ES patients were predominantly male (78 %) and smokers (68 %) and presented diffuse SSc (67 %). Mean time of occupational exposure to silica was 13.7 years, with mean age at onset of 47 years. Previous history of tuberculosis was referred by 33 % of the ES patients. All the ES patients presented Raynaud's phenomenon, esophageal involvement, and interstitial lung disease (ILD). Antinuclear antibodies were present in all the ES patients, while anti-topoisomerase I was positive in 44 % and no patient had anticentromere antibody. Three different HLA-DQB alleles (0506, 0305, and 0303) were observed. Compared to non-ES cases, patients with ES were associated with male gender (p < 0.001), diffuse SSc (p < 0.05), ILD (p < 0.05), positive anti-topoisomerase I antibodies (p < 0.05), and death (p < 0.05). Multivariate analysis did not confirm that silicosis is an independent risk factor for SSc. To conclude, ES was rare in this large SSc cohort, although associated with a bad prognosis.-
dc.description.sponsorshipFederico Foundation, Switzerland-
dc.language.isoeng-
dc.publisherSPRINGER HEIDELBERG-
dc.relation.ispartofRheumatology International-
dc.rightsrestrictedAccess-
dc.subjectSystemic sclerosis-
dc.subjectSilicosis-
dc.subjectErasmus syndrome-
dc.subjectOccupational exposure-
dc.subject.otherconnective-tissue disease-
dc.subject.otheroccupational risk-factors-
dc.subject.otherscleroderma-
dc.subject.othermarkers-
dc.subject.otherworkers-
dc.titleSystemic sclerosis and silica exposure: a rare association in a large Brazilian cohort-
dc.typearticle-
dc.rights.holderCopyright SPRINGER HEIDELBERG-
dc.identifier.doi10.1007/s00296-015-3412-0-
dc.identifier.pmid26759224-
dc.subject.wosRheumatology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalROCHA, Luiza F.:Lusiada Fdn Sch Med, Santos, Brazil-
hcfmusp.author.externalMARANGONI, Roberta G.:Northwestern Univ, Div Rheumatol, Chicago, IL 60611 USA-
hcfmusp.author.externalRIO, Ana Paula Toledo Del:Univ Estadual Campinas, Rheumatol Unit, Campinas, Brazil-
hcfmusp.author.externalMARQUES-NETO, Joao Francisco:Univ Estadual Campinas, Rheumatol Unit, Campinas, Brazil-
hcfmusp.description.beginpage697-
hcfmusp.description.endpage702-
hcfmusp.description.issue5-
hcfmusp.description.volume36-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84954315497-
hcfmusp.origem.idWOS:000374567500011-
hcfmusp.publisher.cityHEIDELBERG-
hcfmusp.publisher.countryGERMANY-
hcfmusp.relation.referenceBurns CJ, 1996, J RHEUMATOL, V23, P1904-
hcfmusp.relation.referenceDospinescu P, 2013, CURR OPIN RHEUMATOL, V25, P179, DOI 10.1097/BOR.0b013e32835cfc2d-
hcfmusp.relation.referenceLeung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9-
hcfmusp.relation.referenceMakol A, 2011, AM J IND MED, V54, P255, DOI 10.1002/ajim.20917-
hcfmusp.relation.referenceRees D, 2007, INT J TUBERC LUNG D, V11, P474-
hcfmusp.relation.referencevan den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098-
hcfmusp.relation.referenceBOVENZI M, 1995, SCAND J WORK ENV HEA, V21, P289-
hcfmusp.relation.referenceMCHUGH NJ, 1994, ARTHRITIS RHEUM, V37, P1198, DOI 10.1002/art.1780370814-
hcfmusp.relation.referenceCLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892-
hcfmusp.relation.referenceDiot E, 2002, OCCUP ENVIRON MED, V59, P545, DOI 10.1136/oem.59.8.545-
hcfmusp.relation.referenceUeki A, 2001, IMMUNOBIOLOGY, V204, P458, DOI 10.1078/0171-2985-00055-
hcfmusp.relation.referenceRUSTIN MHA, 1990, BRIT J DERMATOL, V123, P725, DOI 10.1111/j.1365-2133.1990.tb04189.x-
hcfmusp.relation.referenceRosenman KD, 1999, AM J IND MED, V35, P375, DOI 10.1002/(SICI)1097-0274(199904)35:4<375::AID-AJIM8>3.0.CO;2-I-
hcfmusp.relation.referenceEnglert H, 2000, AUST NZ J MED, V30, P215, DOI 10.1111/j.1445-5994.2000.tb00810.x-
hcfmusp.relation.referenceSampaio-Barros PD, 2012, J RHEUMATOL, V39, P1971, DOI 10.3899/jrheum.111582-
hcfmusp.relation.referenceMagnant J, 2005, J RHEUMATOL, V32, P1713-
hcfmusp.relation.referenceSILMAN AJ, 1992, ANN RHEUM DIS, V51, P1322, DOI 10.1136/ard.51.12.1322-
hcfmusp.relation.referenceKOEGER AC, 1995, MEDICINE, V74, P221, DOI 10.1097/00005792-199509000-00001-
hcfmusp.relation.referenceRanque B, 2010, AUTOIMMUN REV, V9, pA311, DOI 10.1016/j.autrev.2009.11.003-
hcfmusp.relation.referenceMora GF, 2009, J RHEUMATOL, V36, P2383, DOI 10.3899/jrheum.090207-
hcfmusp.relation.referenceMarie I, 2014, AUTOIMMUN REV, V13, P151, DOI 10.1016/j.autrev.2013.10.002-
hcfmusp.relation.referenceSANCHEZROMAN J, 1993, ANN RHEUM DIS, V52, P534, DOI 10.1136/ard.52.7.534-
hcfmusp.relation.referenceERASMUS L D, 1957, S Afr J Lab Clin Med, V3, P209-
hcfmusp.relation.referenceFurukawa H, 2015, CLIN MED INSIGHTS CI, V29, P1-
hcfmusp.relation.referenceMarie I, 2015, J AM ACAD DERMATOL, V72, P456, DOI 10.1016/j.jaad.2014.11.027-
hcfmusp.relation.referenceMiranda AA, 2013, BRAZ J RHEUMATOL, V53, P310-
hcfmusp.relation.referenceRosenman KD, 1996, AM J EPIDEMIOL, V144, P890-
hcfmusp.relation.referenceSLUISCREMER GK, 1985, BRIT J IND MED, V42, P838-
hcfmusp.relation.referenceDel Rio APT, 2013, DIS MARKERS, P73, DOI 10.1155/2013/301415-
dc.description.indexMEDLINE-
dc.identifier.eissn1437-160X-
hcfmusp.citation.scopus17-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/Outros
Outros institutos - HC/Outros

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_ROCHA_Systemic_sclerosis_and_silica_exposure_a_rare_association_2016.PDF
  Restricted Access
publishedVersion (English) 401.13 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.